Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,391 | -5,128 | -3,201 | -1,555 | -3,697 |
| Depreciation Amortization | 7 | 5 | 3 | 1 | 9 |
| Other Working Capital | -83 | -134 | -45 | 333 | 274 |
| Other Operating Activity | -9,778 | -11,189 | -13,926 | -16,736 | -2,336 |
| Operating Cash Flow | $-17,245 | $-16,446 | $-17,169 | $-17,957 | $-5,750 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | -6 | -3 | -21 |
| Other Investing Activity | -183 | -147 | -68 | -21 | -169 |
| Investing Cash Flow | $-191 | $-155 | $-74 | $-24 | $-190 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,265 | 18,265 | 18,265 | 18,265 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -13,954 |
| Other Financing Activity | 600 | 600 | 600 | 600 | -316 |
| Financing Cash Flow | $18,865 | $18,865 | $18,865 | $18,865 | $-14,270 |
| Beginning Cash Position | 736 | 736 | 736 | 736 | 20,946 |
| End Cash Position | 2,165 | 3,000 | 2,358 | 1,620 | 736 |
| Net Cash Flow | $1,429 | $2,264 | $1,622 | $884 | $-20,210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,245 | -16,446 | -17,169 | -17,957 | -5,750 |
| Capital Expenditure | -8 | -8 | -6 | -3 | -21 |
| Free Cash Flow | -17,253 | -16,454 | -17,175 | -17,960 | -5,771 |